Transcript Highlights:

• Food and Drug Administration's approval of MDMA and the U.S.
• to grant coverage for MDMA treatment.
• If I may just take one minute to explain what MDMA is: MDMA is a drug right now that, in the clinical
• A dose of the MDMA, and they have to stay there while the effect is on.
• Just with the MDMA specifically in this bill, it would bring that in. So, Mr.

Bills: SB1161, SB1215, SB1270, SB1400, SB1537, SB1538, SB1580, SB1584, SB1627

Keywords: appropriation, public safety, Yuma County, funding exemption, family advocacy center, firefighters, occupational disease, workers compensation, cancer presumption, police officers, hazardous duty, SB1270, Arizona retirement system, public safety personnel, defined contribution plan, correctional officers, corrections officers, retirement contributions, supplemental contributions, retention incentive

Summary: The committee first heard SB 1161, which would prevent lapse of a $750,000 FY2026 appropriation to DPS for the Yuma County Family Advocacy Center (Amberly’s Place). Testimony described the center’s 24/7 crisis response, forensic interview and medical services, and satellite offices in nearby communities. The bill was moved and received a do pass recommendation on an 11-0 roll call, with three members absent. The committee then considered SB 1215, a clarifying bill on the list of cancers covered by the occupational disease presumption for firefighters and peace officers, with a retroactivity amendment to June 30, 2021. Firefighters’ representatives said the measure corrects a drafting issue involving adenocarcinoma and would prevent denials of claims; members asked about peace officer coverage, independent medical exams, and workers’ compensation impacts. The amendment was adopted and the bill received a do pass recommendation, with 11 ayes, one present, and two absent. SB 1270, dealing with supplemental employer contributions to defined contribution accounts for corrections employees, drew testimony focused on severe retention problems in corrections and county detention. Supporters said the bill would allow optional incentive payments at service intervals to help keep trained officers on the job; members discussed vesting, recruitment versus retention, and whether the program could be funded without a new appropriation. The committee adopted the amendment and gave the bill a do pass recommendation, with ten ayes, one nay, two present, and one absent. The committee also heard SB 1400, authorizing law enforcement wellness and crisis response programs and setting confidentiality rules. Police association testimony supported the concept but noted concerns about the breadth of the privilege carve-outs, especially if licensed therapists are involved; several members said they would support the bill after an amendment clarifying privilege protections. The bill was reported do pass with ten ayes, one nay, and two present. SB 1538, as a strike-everything amendment, would require workers’ compensation coverage for PTSD treatment for firefighters and peace officers and allow one MDMA treatment course if federal approval and rescheduling occur by January 1, 2029. Supporters described promising clinical trial results and argued it could help severe PTSD cases, while county representatives opposed the mandate and raised cost and approval concerns. The amendment was adopted and the bill received a do pass recommendation, with seven ayes, three nays, and one present. Finally, the committee considered SB 1537, renaming the peace officer training equipment fund as the public safety de-escalation and life safety fund and repealing its advisory commission. Testimony explained the change was meant to reduce confusion between similar funds and reflect the fund’s use for de-escalation and safety equipment; some members noted opposition from the Arizona Police Association and concerns about whether the money might be better used for raises. The bill passed on a 7-4 vote with three absent. The committee then began SB 1580, which would appropriate Peace Officer Training Equipment Fund money for fire incident management support and other public safety equipment, including pepperball equipment, simulators, records management software, and retention/recruitment efforts. Testimony supported the equipment and data-sharing investments, but members also questioned accountability, ongoing costs, and whether the listed uses were the best use of the fund.

Transcript Highlights:

• Even MDMA has been used therapeutically since the early 1900s.
• Even MDMA has been used therapeutically since the early 1900s.
• Even MDMA has been used therapeutically since the early 1900s.
• Even MDMA has been used therapeutically since the early 1900s.
• Even MDMA has been used therapeutically since the early 1900s.

Keywords: 912, senate, all

Summary: The Health and Human Services Committee heard testimony on several measures related to child welfare, health care access, overdose response, disability services, and waste management. For SB 710 on child welfare, the Department of Human Services, the Office of Wellness and Resilience, the Attorney General’s office, and multiple advocacy groups testified in support, with the Governor’s office noting support but deferring to the Attorney General on implementation because of separation-of-powers concerns. For SB 952 on child welfare services, DHS, the Governor’s office, and child- and trauma-informed care advocates supported the bill, saying it would help families access services, provide basic material support, and reduce strain on the child welfare system. SB 954 on a home health services rate study also drew support, including from DHS, the Hawaii Healthcare Association, and a public testifier who said the study would help ensure funds reach low-income, disabled, and kupuna recipients. SB 957 on overdose prevention received support from the Department of Health and the Attorney General, who said overdose prevention centers are evidence-based but raised federal-law concerns and recommended amendments; the Hawaii Health and Harm Reduction Center and others also testified in support. The committee then moved to the 1:00 regular calendar and heard SB 850 on disability health disparity, which was supported by the Executive Office on Aging, the Hawaii State Council on Developmental Disabilities, the Hawaii Disability Rights Center, self-advocates, and others. Testimony emphasized that a disparity study could improve workforce development, training, and services for people with disabilities. SB 838 on continuous glucose monitoring drew support from health agencies and advocates, with testimony stressing that monitors can be critical for some diabetes patients. SB 829 on health care was supported by the Department of Health and health care stakeholders, who said it would help rotating physicians serve neighbor islands without local hospital privileges and align with CMS rules. SB 446 on waste management drew mixed testimony: the Department of Health and several public entities provided comments, the County of Maui opposed, and environmental advocates urged stronger aquifer protections and limits on ash reuse. During decision making, the committee adopted recommendations to pass SB 298, SB 322, SB 299, SB 450, SB 451, SB 949, SB 710, SB 957, SB 69, and SD 952 with various amendments, including technical changes, blank appropriations, and defective dates. SB 323, SB 324, SB 712, SB 950, SB 954, and SB 959 were deferred, largely because companion House measures were moving or similar Senate measures had already passed. The chair also announced recesses to find quorum and noted that some bills from the earlier Monday calendar were being deferred to avoid duplication.

Transcript Highlights:

• The bill prescribes criteria for grant applications and codifies MDMA in statute as whatever official
• I'll just tell you a little bit about MDMA.
• MDMA came up a few years ago, and I'm going to quote Dr.
• What MDMA does is it's been in the clinical trials for a long time.
• MDMA is— they issue three doses. The affected person is in a chair with a counselor.

Bills: SB1071, SB1315, SB1317, SB1416, SB1493, SB1537, SB1542, SB1584, SB1626, SB1740, SB1751, SB1804, SCR1047, SCR1049

Keywords: Arizona Rangers, statutory repeal, security, state law, regulatory changes, school safety, interoperable communications, law enforcement, emergency response, funding, reentry programs, criminal justice, grants, recidivism, attorney general, missing children, kidnapping, reporting requirements, child safety, training

Summary: The committee first took up SB 1071, which would repeal the statutory framework for the Arizona Rangers. The sponsor argued the bill was about accountability and transparency, citing concerns about missing training and firearms qualification records; Arizona Rangers representatives and several sheriffs opposed the bill, saying the Rangers provide valuable volunteer support and that the real issue was adding oversight rather than eliminating protections. After discussion, the committee voted 4-3 to give SB 1071 a do pass recommendation, with members noting they expected amendments later. The committee then heard SB 1315, requiring school districts and charter schools to maintain interoperable emergency communications with law enforcement and to submit annual affidavits confirming testing and compliance. Testimony from school safety officials and sheriffs emphasized the value of real-time communication during emergencies and the need for secure sharing of campus maps and floor plans; concerns about cost and information security were addressed by supporters. The bill passed unanimously, 7-0. The committee also advanced SB 1317, which appropriates opioid settlement funds for county reentry planning programs; sheriffs and association representatives supported it, citing reduced recidivism and jail populations, and it passed 7-0. Several public safety and missing-children measures were considered next. SB 1416, as amended, revises missing child reporting requirements, adds runaway children back into reporting, requires faster photo and information sharing, and expands training requirements; advocates for missing children and law enforcement supported the compromise language, and the bill passed 7-0. SB 1740, which updates Turquoise Alert training and procedures, was also advanced 7-0 after discussion about statewide versus geographically targeted alerts and the need to keep alerts effective. Later, SB 1493, a strike-everything amendment affecting police officer termination appeals and fee shifting when an employer rejects a favorable administrative ruling, passed 5-2 despite opposition from chiefs’ representatives. SB 1537, renaming the Peace Officer Training Equipment Fund and repealing its advisory commission, passed 5-2. The committee also approved SB 1751 and SCR 1049, which expand execution methods to include lethal gas and firing squad and make firing squad mandatory in certain cases involving the murder of a law enforcement officer; opponents raised constitutional, ethical, and practical concerns, while supporters framed the measures as aligning Arizona with other states and providing additional options. Both measures passed 4-3. Finally, SB 1542, which would create a framework and funding for MDMA research and treatment for PTSD in first responders and peace officers contingent on FDA approval, was heard with testimony describing promising clinical trial results and the need for Arizona research; the bill was then moved forward, though the transcript cuts off before the final roll call result is fully shown.

Transcript Highlights:

• The pilot program will support clinical research into FDA-designated breakthrough therapies like MDMA
• I'm also a MAPS MDMA-trained facilitator.
• I'm also a MAPS MDMA-trained facilitator.
• plant medicines I'm also a Maps MDMA plant medicines I'm also a Maps MDMA trained trained trained
• So virtually no patients have access to psilocybin or MDMA until approval.

Keywords: 910, house, all

Transcript Highlights:

• As MDMA, this is ecotherapy. So this is my plea and my advocacy.
• In just one carefully guided MDMA session, I achieved more healing than in the decades of prior work.
• my body was somatically released through the clenching and unclenching of my muscles, helped by the MDMA
• Australia, a civilized Western nation, already told its providers they can prescribe psilocybin and MDMA
• about psychedelic treatments for veterans, and I've learned about the remarkable effectiveness of MDMA

Keywords: 995, all

Summary: The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback. A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use. The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care. Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.

Transcript Highlights:

• They said the therapies the pilot would focus on would be psilocybin and MDMA, both of which have been
• She said she has led studies as a researcher and clinician on novel rapid-acting therapies like MDMA
• <01:16:10.040> trained also a Maps MDMA trained also a Maps MDMA trained facilitator<01:16
• which have both still a sibin and MDMA which have both been<01:18:37.080> granted<01:18:37.560
• got that designation was reasons MDMA got that designation was because<01:18:45.040> in<01:18

Keywords: 910, house, all

Summary: The Committee on Health heard testimony on several bills. On SB 1441, which would repeal the transfer of the Oahu Regional Health Care System from HHSC to the Department of Health, the Department of Health said it strongly supports the measure and requested clarifying amendments. HHSC/Oahu Region also supported the bill and said it had no objection to the department’s amendments. In response to questions, witnesses said the agencies have been working on an MOU to support transfers of long-term care patients to Leahi, with the current goal being about 10 to 15 patients, but transfers would occur only as space and staffing allow; one patient was reportedly being admitted at the time, and the process was described as slow and case-by-case. The committee then heard SB 1443 on payment rates for state hospital patients and related Department of Health services. The hospital administrator said the bill would allow rates above Medicaid for community or foster-home placements if patients cannot be placed at Leahi or elsewhere, and would set Medicaid-level reimbursement for outside medical services used by state hospital patients. He said at least one provider was interested in offering services at that rate and that the population involved is largely non-ambulatory long-term care patients. Members asked about availability and training, and the witness said special training could be provided. SB 1322, a broad mental health bill, drew mixed testimony. The Department of Law Enforcement supported giving crisis-intervention-trained officers more discretion to transport people to medical care instead of arresting them. The Attorney General supported the bill but recommended revisions to emergency-transport language and restoring liability protections. HHSC and Queens Hospital supported the overall goal but sought amendments to preserve the mental health emergency worker role in decision-making and to avoid negative impacts on emergency departments. The Disability Rights Center and ACLU opposed parts of the bill, arguing that it weakens due process, reduces protections in involuntary treatment and transport, and should retain a three-person treatment panel rather than reduce it to one. A Queens representative said the current program works well and reported that more than 90% of MH1 cases once went to hospitals, but that figure has dropped to about 60-70%, with about 20% now diverted to community settings or the behavioral health crisis center. No votes or final committee actions were taken in the portion provided.

Transcript Highlights:

• MDMA assisted therapy shows long-term PTSD symptom reduction lasting years.
• MDMA<00:04:34.240> assisted<00:04:34.639> therapy<00:04:34.960> shows<00:04:35.199
• > long-term MDMA assisted therapy shows long-term MDMA assisted therapy shows long-term PTSD<00
• There's ibogaine, there's MDMA, there's ketamine, there's psilocybin, there's different things.
• ,<00:27:05.200> there's there's MDMA, there's Kamin, there's there's MDMA, there's Kamin,

Keywords: 912, senate, all

Summary: The committee heard testimony on SB 3025, relating to medical debt, with multiple organizations and individuals, including the Office of Wellness and Resilience, Healthcare Association of Hawaii, Queens Health Systems, the American Cancer Society Cancer Action Network, Aloha Care, Hawaii Health and Harm Reduction, Hawaii Data Collaborative, and Hawaii Appleseed, all speaking in support. No opposition was heard, and the member present had no questions. The committee then took up SB 3199, which would establish a mental health emerging therapies task force. Testimony was overwhelmingly in support, with speakers including veterans, clinicians, researchers, and advocacy groups describing personal experiences with PTSD, depression, traumatic brain injury, and treatment-resistant conditions, and arguing that Hawaii should prepare for regulated access to emerging therapies such as MDMA, psilocybin, ketamine, and ibogaine. The Department of Health and some medical organizations provided comments, and one opposition witness was called but not present. The chair noted broad support, especially from veterans, and no vote was taken during the excerpt. The final measure discussed was SB 3324, relating to Medicaid. The Department of Human Services, Department of Health, Hawaii State Council on Developmental Disabilities, Hawaii Disability Rights Center, Aloha Care, and numerous care-provider and aging/disability organizations testified in support, while one witness was in opposition and several others offered comments. The discussion then moved to SB 2563, relating to homelessness, where the Department of the Attorney General offered comments on specific sections and recommended adopting suggested amendments if the bill proceeds. Additional testimony on SB 2563 began with support from several individuals, including Shelby Pikachu, who emphasized the severity of homelessness and related social problems in the community.

Transcript Highlights:

• Members, you may be aware that there are certain Schedule I controlled substances, psilocybin and MDMA
• by considering a rescheduling as soon as the FDA approved one of these interventions, for example, MDMA
• So when the FDA approves any Schedule I drug, in this case certainly MDMA or psilocybin would be the
• Representative Olverson continued that MDMA or psilocybin would be the most likely to get that as a first
• He said this bill really primarily deals with psilocybin and MDMA that are in phase three clinical trials

Bills: HB216

Keywords: HB216, Texas abortion law, abortion-inducing drug, medication abortion, mifepristone, misoprostol, telemedicine, in-person exam, physician presence, out-of-state physician, reproductive healthcare, abortion regulation, Health and Safety Code, Occupations Code, consultation services, remote prescribing, pro-life, pro-choice

Summary: The Committee on Public Health met with a quorum and heard public testimony on a long agenda, with members repeatedly reminded of a two-minute limit for witnesses. Several bills were voted out favorably, including HB 2588 on cottage food, HB 1639 on cancer incidence and female firefighters, HB 2581 on a reporting form for contracted services for pregnant women, and SB 922 on electronic disclosure of certain sensitive medical information. Those measures generally passed on party-line or near-unanimous votes, while HB 216 on itemized medical statements was left pending after the committee substitute was withdrawn. The committee also left pending HB 5141, HB 4638, HB 2035, HB 4813, HB 2264, HB 4014, and HB 3829 after hearing testimony and questions. The final item introduced in the excerpt was HB 4408 on health care market transparency and corporate consolidation, but the discussion was cut off before testimony or action was completed. A major theme of the hearing was mental health diversion and access to treatment. HB 5141, by Rep. Howard, would allow Travis County to use vacated Austin State Hospital property for a local mental health jail diversion center; law enforcement, the Travis County sheriff, county judge, and urban counties group all testified in support, describing the lack of alternatives for people in crisis and the burden on jails and emergency rooms. Members asked about eligible offenses, bed capacity, and whether the facility would serve only Travis County, and the bill was left pending. HB 2264, by Rep. Schoolcraft, would create a friends-and-family form for loved ones to provide information to providers during emergency mental health treatment; NAMI and hospital groups supported it, while one neutral witness and several members raised concerns about patient control, credibility of information, and liability protections. The bill was also left pending. The committee also heard multiple psychedelic-therapy and drug-policy bills. HB 4813 would speed Texas rescheduling of Schedule I substances if the FDA reclassifies them, with testimony focused on psilocybin and MDMA and their potential use for PTSD and depression; members questioned whether the bill was too broad and how state rescheduling works, and it was left pending. HB 4014 would direct HHSC to study psychedelic therapies, building on prior state research, and witnesses said Texas should prepare regulatory and clinical infrastructure before FDA approval; it too was left pending. HB 2035 would require parents to be informed that they may seek substance-use treatment for a child even if one facility turns them away, prompted by a constituent’s account of a fatal fentanyl overdose after receiving incorrect advice; it was left pending. HB 4638 would extend and expand the Texas Pharmaceutical Initiative board and timeline, with the author saying the program is still in early implementation and needs more time, and it was left pending as well. Other bills addressed public health administration and animal welfare. HB 3829 would require a study of the animal-friendly account and its grant process for spay/neuter funding, with the author arguing that the current application and reimbursement process is too burdensome for shelters and nonprofits; no opposition was heard and the bill was left pending. HB 2581 and HB 1639 were reported favorably, while HB 216 drew discussion about enforcement of itemized medical billing and was held after the committee substitute was withdrawn. Throughout the hearing, members also discussed broader concerns about homelessness, competency restoration waitlists, jail overcrowding, and the need for more treatment options outside the criminal justice system.

Transcript Highlights:

• Members, you may be aware that there are certain Schedule I control substances, psilocybin and MDMA.
• by considering a rescheduling as soon. as the FDA approved one of these interventions, for example, MDMA
• So when the FDA approves. any schedule, and I think in this case, certainly MDMA or psilocybin would
• So yes, so this this is a This bill really primarily deals with psilocybin and MDMA that are in phase
• compounds including psilocybin for treatment resistant depression and major depression disorder. and MDMA

Bills: HB5141, HB4638, HB2264, HB2035, HB4813, HB4408, HB2684, HB1621, HB2300, HB216, HB3829, HB4466, HB1747, HB2284, HB3614, HB2587, HB3219, HB3318, HB5147, HB4014, HB216

Keywords: lease, state property, public purpose, Travis County, Health and Human Services, pharmaceutical initiative, drug distribution, healthcare services, generic drugs, advanced pharmaceuticals, cost savings, mental health, patient discharge, medical records, health care professionals, substance use, family involvement, chemical dependency, treatment facilities, minor admissions

Transcript Highlights:

• firefighters and peace officers diagnosed with PTSD and allows coverage to include one complete course of MDMA
• treatment contingent on FDA approval and the DEA's rescheduling of MDMA.

Keywords: 1182, all

Summary: The caucus reviewed a long agenda of Senate bills across elections, commerce, education, government, health and human services, judiciary, public safety, transportation, rural development, and ways and means. Many measures were described as consent or third-read consent items, including bills on campaign finance termination statements and late-report penalties, AI provenance data for media, adjuster/contractor conduct during emergencies, Industrial Commission changes, association meeting closures, banking and remittance rules, central bank digital currency, public safety parity funding, barbering and cosmetology board continuation, digital asset reserve management, contractor licensing, gaming and racing commission continuation, school AED instruction, classroom removal procedures, school safety reporting, special education complaint transparency, foreign influence and land ownership restrictions, DCS and DES process changes, health care licensing and reimbursement rules, EMS compact adoption, and multiple tax, housing, and transportation measures. Staff repeatedly summarized each bill and answered questions, with several bills noted as mirror or identical to House measures or as strike-everything amendments from committees. A few bills drew discussion. On SB 2874, staff explained that the Senate amendment would limit penalties for untimely campaign finance reports when a committee certifies it received no contributions and made no expenditures, but the sponsor did not concur. SB 1074 prompted questions about whether parental notification changed; staff said it did not and that the bill was aimed at improving communication between teachers and principals about discipline. SB 1175, requiring DCS caseworkers to photograph children at each interaction in abuse or neglect cases, drew concern about the scope of the photos, while supporters said it would improve continuity and documentation. SB 1180 also drew comment because the sponsor and committee chair disagreed over an amendment, though the bill was advanced for further work. The most extended debate came on SB 1751, which would allow death-row inmates to choose firing squad, lethal injection, or lethal gas if voters approve the related constitutional measure. One member strongly opposed the bill on moral and personal grounds, another argued it could be a more humane option if the state is going to carry out executions, and a third raised concern that it could be used against Second Amendment rights. The bill remained on the third-read consent calendar despite the objections. The caucus concluded after moving through the remaining agenda items, with no formal votes recorded in the transcript beyond committee status and consent-calendar placement.

Transcript Highlights:

• With PTSD, with MDMA, we're seeing 88% experiencing symptom relief and 67% achieving remission.
• When combined with psychological support, psychedelic compounds like psilocybin, LSD, 5-MeO, DMT, and MDMA

Keywords: 1182, all

Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies met to discuss psychedelic-assisted treatments for serious mental health conditions, with a focus on psilocybin, ibogaine, MDMA, and related compounds. The chair framed the issue as a clinical and access problem for veterans, first responders, and others with PTSD, depression, TBI, addiction, and suicidal ideation, emphasizing that these therapies are intended for supervised medical settings rather than take-home use. Members reviewed research claims and policy trends, including FDA breakthrough therapy designations, state-level psychedelic legislation, and the role of Arizona’s right-to-try law in expanding access once federal approval is in place. Testimony came from Alan Mullen, a retired Army Special Forces veteran, who described his PTSD/TBI history and said ibogaine treatment helped him confront trauma and showed promise in reducing symptoms under strict medical monitoring. Dr. Sue Cisley of Scottsdale Research Institute described ongoing FDA-controlled trials in Arizona, said current medications often fail high-need patients, and urged removal of research barriers and preparation for right-to-try and expanded access. Dan Freiberg of the Professional Firefighters of Arizona said firefighters face chronic exposure to trauma, often rely on alcohol or other coping mechanisms, and need effective alternatives beyond traditional therapy. Dr. Chung Trin discussed late-stage psychedelic trials, the FDA breakthrough pathway, safety oversight, and the need for state readiness when approvals occur. Committee members asked about how the treatments work, whether they require psychotherapy support, safety concerns including suicidality and black-market abuse, patenting and synthetic versus natural versions, and costs compared with ketamine and other treatments. Witnesses said the therapies are administered with extensive screening, monitoring, and integration support, and argued that addiction potential appears low under medical supervision. The discussion ended with interest in sending correspondence to federal officials to support right-to-try cooperation and in continuing the research and policy work; no formal vote or action was taken in the portion provided.

Transcript Highlights:

• Treatments that have shown potential include HBOT, medical cannabis, MDMA, and other plant-based alternatives
• These include psychedelics such as MDMA, psilocybin, and ibogaine.

Keywords: veteran services, Secretary Collins, healthcare provisions, contract cancellations, transparency, accountability, committee meeting, legislation

Summary: During this committee meeting, various bills were discussed with a specific focus on veteran services and healthcare provisions. Notably, the cancellation of critical contracts under Secretary Collins sparked significant debate, with representatives emphasizing the adverse impact on veteran care. The meeting featured testimonies from veterans and stakeholders who expressed their concerns regarding the potential fallout of these cancellations, demonstrating the urgency of transparency and accountability in management decisions. Discussions also delved into various legislative proposals aimed at improving services for veterans amidst these challenges.

Transcript Highlights:

• or a main focus of many, if any, clinical trials that are currently going on, whereas psilocybin, MDMA
• Like psilocybin, MDMA, are not known to be habit-forming drugs. And you can get into it.
• lot of these molecules we talk about are actually not habit-forming medications, like psilocybin, MDMA

Keywords: 995, all

Summary: The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research. A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911. The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use. Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.

Transcript Highlights:

• In this case, ibogaine is being confused with MDMA because both can be used to treat PTSD.
• MDMA does cause people to relive their trauma, but ibogaine does not.

Keywords: 958, all

Transcript Highlights:

• a decade ago by a former Chicago police officer whose daughter was poisoned with a lethal dose of MDMA

Keywords: 959, house, all

Transcript Highlights:

• It was nice to collaborate with Cherry Bliss, Representative Duran, as well as and MDMA.

Transcript Highlights:

• In December of 2024, the VA announced $1.5 million in funding for clinical research on MDMA-assisted
• While MDMA-assisted therapy did not receive FDA approval last summer, approval of certain psychedelic
• While MDMA-assisted therapy did not receive FDA approval last summer, approval of certain psychedelic
• Emerging VA studies involving MDMA and psilocybin show remarkable potential, not just for improvement
• Emerging VA studies involving MDMA and Emerging VA studies involving MDMA and psilocybin<03:29:25.840

Keywords: U.S. House of Representatives Floor Proceedings on Wednesday, June 25, 2025, 1012, house, all

Transcript Highlights:

• marijuana, 31,000 grams of THC, and nearly 20,000 grams of other narcotics, including heroin, LSD, MDMA

Keywords: 1184, house, all

Transcript Highlights:

• And nearly 20,000 g of other narcotics including heroin, LSD, MDMA.

Transcript Highlights:

• Chair Bliss, first of all, for ibogaine and other psychedelics such as LSD, MDMA, that have incredible
• why I'm thankful for partnerships across the aisle and wherever we can. psychedelics such as uh LSD, MDMA
• that psychedelics such as uh LSD, MDMA that have<01:12:29.199> um<01:12:29.679> incredible

Bills: HF4588, HF3685, HF4577, HF4932

Keywords: veterans, veterans affairs, mental health, behavioral health, rural health, rural areas, access to care, task force, Minnesota Department of Veterans Affairs, general fund appropriation, veteran suicide prevention, PTSD, service members, military families, telehealth, rural psychiatry, high school diploma, armed forces, education policy, military service